MX2011010835A - Composicion farmaceutica sublingual que comprende un aceite neutral. - Google Patents

Composicion farmaceutica sublingual que comprende un aceite neutral.

Info

Publication number
MX2011010835A
MX2011010835A MX2011010835A MX2011010835A MX2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
neutral oil
sublingual pharmaceutical
sublingual
oil
Prior art date
Application number
MX2011010835A
Other languages
English (en)
Inventor
Clive Booles
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2009/050416 external-priority patent/WO2010122276A1/en
Priority claimed from GB0906977A external-priority patent/GB2469792A/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Publication of MX2011010835A publication Critical patent/MX2011010835A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

La invención proporciona composiciones farmacéuticas para el suministro sublingual de medicamentos que comprenden un aceite neutro y un medicamento soluble en tal aceite, con la condición de que tal medicamento no sea nitroglicerina. La invención también proporciona dispositivos de tratamiento adaptados para suministro sublingual de tales composiciones.
MX2011010835A 2009-04-23 2010-04-23 Composicion farmaceutica sublingual que comprende un aceite neutral. MX2011010835A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2009/050416 WO2010122276A1 (en) 2009-04-23 2009-04-23 Drug delivery
GB0906977A GB2469792A (en) 2009-04-23 2009-04-23 Oil-based pharmaceutical formulation for sublingual delivery
PCT/GB2010/050671 WO2010122355A1 (en) 2009-04-23 2010-04-23 Sublingual pharmaceutical composition comprising a neutral oil

Publications (1)

Publication Number Publication Date
MX2011010835A true MX2011010835A (es) 2012-05-08

Family

ID=42236683

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010835A MX2011010835A (es) 2009-04-23 2010-04-23 Composicion farmaceutica sublingual que comprende un aceite neutral.

Country Status (15)

Country Link
US (1) US20120058158A1 (es)
EP (1) EP2421503A1 (es)
JP (1) JP2012524771A (es)
CN (1) CN102458358A (es)
AU (1) AU2010240653A1 (es)
BR (1) BRPI1013539A2 (es)
CA (1) CA2756879A1 (es)
IL (1) IL215454A (es)
MX (1) MX2011010835A (es)
MY (1) MY167918A (es)
NZ (1) NZ595467A (es)
RU (1) RU2011139638A (es)
SG (1) SG175160A1 (es)
WO (1) WO2010122355A1 (es)
ZA (1) ZA201107089B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
MX337286B (es) 2007-05-25 2016-02-22 Indivior Uk Ltd Formulaciones de transferencia sostenida de compuestos de risperidona.
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US20130254139A1 (en) * 2012-03-21 2013-09-26 Xiaoguang Lei Systems and methods for building a universal intelligent assistant with learning capabilities
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US10376586B2 (en) * 2016-02-16 2019-08-13 Entourage Bioscience, LLC Method and compositions for solubilizing non-polar constituents
EP3452023A1 (en) 2016-05-05 2019-03-13 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US11000487B2 (en) * 2016-12-26 2021-05-11 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
CA3076816A1 (en) * 2017-09-27 2019-04-04 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
IL296719A (en) * 2020-03-31 2022-11-01 Nomoreitis B V Treatment of hyperinflammatory syndrome

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4869899A (en) * 1986-03-10 1989-09-26 Walter Burghart Pharmaceutical preparation and process for producing the same
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
WO2002064109A2 (en) * 2001-02-14 2002-08-22 Gw Pharma Limited Mucoadhesive pharmaceutical formulations
MX2008009522A (es) * 2006-01-25 2009-01-07 Insys Therapeutics Inc Rocio de fentanilo sublingual.
WO2009020666A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
CN102395362B (zh) * 2009-04-23 2014-07-02 伦敦制药有限公司 含二氢青蒿素的舌下喷雾制剂

Also Published As

Publication number Publication date
JP2012524771A (ja) 2012-10-18
CA2756879A1 (en) 2010-10-28
AU2010240653A1 (en) 2011-10-20
IL215454A (en) 2014-11-30
EP2421503A1 (en) 2012-02-29
SG175160A1 (en) 2011-11-28
US20120058158A1 (en) 2012-03-08
WO2010122355A1 (en) 2010-10-28
IL215454A0 (en) 2011-12-29
ZA201107089B (en) 2012-12-27
MY167918A (en) 2018-09-27
NZ595467A (en) 2013-08-30
BRPI1013539A2 (pt) 2016-04-12
CN102458358A (zh) 2012-05-16
RU2011139638A (ru) 2013-05-27

Similar Documents

Publication Publication Date Title
MX2011010835A (es) Composicion farmaceutica sublingual que comprende un aceite neutral.
TN2011000471A1 (en) Pharmaceutical composition presenting anti-inflammatory properties
MY160456A (en) Benzodiazepine bromodomain inhibitor
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
PH12015501737A1 (en) Androgen receptor modulators and uses thereof
MX2009010289A (es) Composiciones para administracion nasal.
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
MX2009007254A (es) Composiciones de tableta en tableta.
IN2012DN02805A (es)
EP2045251A4 (en) COMPOUNDS WHICH CAN INCLUDE THE UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
MX2011013176A (es) Motivos de modificación química para inhibidores y miméticos del miarn.
PL2083809T3 (pl) Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji
MX2010002815A (es) Composiciones farmaceuticas que contienen toxoides a y b de clostridium difficile.
TN2012000059A1 (en) Compositions comprising tramadol and celecoxib in the treatment of pain
PL2081547T3 (pl) Postać galenowa do podawania składników czynnych poprzez śluzówkę
PH12015501096A1 (en) Composition for immediate and extended release
WO2012174158A3 (en) Administration of benzodiazepine
MX2013000642A (es) Composiciones farmaceuticas.
AU2012347200A8 (en) Tablet capable of combatting misuse by injection
DK201270677A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
TW200738627A (en) Trialkylsilyl-indoles
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
GB201014391D0 (en) Drug composition and its use in therapy
EA201171414A1 (ru) Ингибиторы белков семейства iap

Legal Events

Date Code Title Description
FG Grant or registration